Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 12 2007 000 013.8 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Ethinylestradiol als Ethinylestradiol-Betadex-Clathrat, Drospirenon |
54 | Title of basic patent | TIGZ | FESTE ARZNEIFORMEN, ENTHALTEND CLATHRATE VOM STEROIDALEN SEXUALHORMON ETHINYLESTRADIOL |
51 | IPC main class | ICM (ICMV) | A61K 47/48 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/567 (2006.01) |
94 | Start of term of protection | LB | Jul 11, 2015 |
22 | DE application date | DAT | Jan 4, 2007 |
| Date of publication of application for a certificate | OT | Apr 26, 2007 |
71/73 | Applicant/owner | INH | Bayer Pharma Aktiengesellschaft, Müllerstr. 178, 13353 Berlin, DE |
| Address for service | | Bayer Pharma Aktiengesellschaft, 13353 Berlin, DE |
| Patent division in charge | | 41 |
68 | DE file number of basic patent | GAKZ | 595 10 887.3 |
68 | EP file number of basic patent | GEAKZ | 95 94 3492.9 |
43 | Date of first publication | EVT | Apr 26, 2007 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 64268.00.00 2006-07-04
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Bundesinstitut für Arzneimittel und Medizinprodukte Deutschland 64268.00.00 2006-07-04
|
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 6, 2024 (Show all update days)(Hide all update days)- Aug 6, 2024
- St.36: changed (technical change)
- Jul 16, 2019; Dec 3, 2016; Nov 4, 2016; Sep 7, 2016; Jul 11, 2015; May 16, 2015; Feb 26, 2014; Mar 16, 2013; Feb 10, 2013; Jun 14, 2012; May 10, 2012; Mar 16, 2012; Mar 15, 2012; Mar 10, 2012; Mar 9, 2012; Nov 1, 2011; Oct 8, 2011; Oct 7, 2011; 31.05.2011; May 31, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|